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Insulin resistance in modern society is perceived as a pathological consequence of excess
energy consumption and reduced physical activity. Its presence in relation to the devel-
opment of cardiovascular risk factors has been termed the metabolic syndrome, which
produces increased mortality and morbidity and which is rapidly increasing in human pop-
ulations. Ironically, insulin resistance likely evolved to assist animals during food shortages
by increasing the availability of endogenous lipid for catabolism while protecting protein
from use in gluconeogenesis and eventual oxidation. Some species that incorporate fast-
ing as a predictable component of their life history demonstrate physiological traits similar
to the metabolic syndrome during prolonged fasts. One such species is the northern ele-
phant seal (Mirounga angustirostris), which fasts from food and water for periods of up
to 4 months. During this time, ∼90% of the seals metabolic demands are met through
fat oxidation and circulating non-esterified fatty acids are high (0.7–3.2 mM). All life history
stages of elephant seal studied to date demonstrate insulin resistance and fasting hyper-
glycemia as well as variations in hormones and adipocytokines that reflect the metabolic
syndrome to some degree. Elephant seals demonstrate some intriguing adaptations with
the potential for medical advancement; for example, ketosis is negligible despite significant
and prolonged fatty acid oxidation and investigation of this feature might provide insight into
the treatment of diabetic ketoacidosis. The parallels to the metabolic syndrome are likely
reflected to varying degrees in other marine mammals, most of which evolved on diets
high in lipid and protein content but essentially devoid of carbohydrate. Utilization of these
natural models of insulin resistance may further our understanding of the pathophysiology
of the metabolic syndrome in humans and better assist the development of preventative
measures and therapies.
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INTRODUCTION
Dyslipidemia,altered glucose metabolism,and hypertension are all
hallmark characteristics of the metabolic syndrome that are often,
but not always, associated with obesity. It has been argued that
the logical predecessor that binds these cardiovascular risk factors
together is insulin resistance (1). Insulin resistance, however, is
not uniform across the tissues of an organism and there is obvious
differentiation in insulin resistance between hepatic, adipose, and
muscle tissues. There is also considerable debate over the causative
nature and interaction of factors contributing to insulin resistance
with lipid partitioning, adipocytokines (particularly adiponectin),
and the contribution of reactive oxygen species at the forefront of
the discussion. Treatment and prevention of the metabolic syn-
drome is of increasing concern due to the rapid increase in its
occurrence, which exceeds 30% of the adult U.S. population and
which shows a continuing upward trajectory (2, 3).
Insulin resistance is today almost ubiquitously viewed as a
pathological phenomenon. Ironically, from an evolutionary per-
spective, insulin resistance likely served as an adaptive response to
increased demands for endogenous nutrient stores as might occur
during injury or starvation (4, 5). Under such situations, mobi-
lization of fat stores and reductions in the demand for glucose by
non-glucose dependent tissues would be facilitated by reductions
in insulin signaling. In the modern world, chronic energy surplus
combined with reduced physical activity results in excess fat depo-
sition, lipid overflow into non-adipose tissues, and inflammation
of adipose tissue, all of which contribute to insulin resistance and
increased morbidity (4).
Traditional animal models for the study of the metabolic syn-
drome and diabetes typically include rodents (e.g., the Zucker dia-
betic fatty rat or Goto-Kakizaki rat), felines, swine,and primates (6,
7). Model species may naturally exhibit diabetes or the metabolic
syndrome or may have diabetic-like states induced via dietary,
genetic, or pharmacological manipulations (8). Traditional ani-
mal models are typically selected because of the similarity between
humans and the animal model with regard to specific pathological
traits of interest. However, there is no single traditional animal
model which exactly mimics diabetes or the metabolic syndrome
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in humans and little work has been performed in non-traditional
or exotic animal models.
Insulin declines with the progression of fasting in humans,
facilitating lipolysis while insulin resistance increases (9, 10). This
adaptive feature under the constraint of nutrient deprivation is
hardly constrained to humans and appears to be a universal
response to food deprivation, at least among mammals. Some
mammals incorporate predictable periods of fasting as a compo-
nent of their life histories and the development of insulin resistance
within the progression of a fast is likely critical to their ability
to regulate endogenous nutrient use across the fast. The north-
ern elephant seal (Mirounga angustirostris) is one of a handful
of mammalian species that couples complete fasting from food
and water with energetically costly activities such as lactation,
intrasexual competition, molting, and post-natal ontogeny. These
prolonged fasts occur twice each year in association with the peri-
ods that the seals are on land; elephant seals are the most aquatic
of the seals and will spend 8–10 months of the year at sea while
on foraging migrations. Upon arrival to land, or upon weaning
(for pups), up to 50% of the elephant seal’s mass is due to adipose
stores, specifically blubber, a non-visceral fat depot. The time fast-
ing on land ranges from∼25 days (lactating females) to 4 months
(sexually competitive males) with intermediate fasting durations
experienced by pups, juveniles, and molting seals of all age classes.
Elephant seals demonstrate a moderate fasting hyperglycemia,
a muted insulin release in response to a glucose challenge, fast-
ing hyperlipidemia, and peripheral insulin resistance (details dis-
cussed below). Although the fasting levels of circulating glucose
may not always exceed the clinical threshold typical for diagnosing
diabetes, the glucose levels and characteristics of the glucoreg-
ulatory system are similar to those of the metabolic syndrome.
However, unlike humans in whom the condition is pathologi-
cal, the shared characteristics of the metabolic syndrome in the
northern elephant seal enable it to manage the fate of endogenous
nutrients and reproduce and develop under conditions in which it
is isolated from food sources for weeks to months. Here we review
glucose metabolism and insulin resistance in the northern ele-
phant seal insofar as it parallels and differs from the physiological
characteristics of the metabolic syndrome. It is necessary, however,
at the outset to distinguish between the different age and repro-
ductive categories of the elephant seal that have been studied as
the age and reproductive status strongly influences glucose metab-
olism within this species. Below, a brief description of the different
classes of seal is given. This is then followed by a discussion of what
is known about glucose metabolism and insulin resistance in this
species, characteristics that make the elephant seal an atypical but
potentially useful model of the metabolic syndrome.
LIFE HISTORY STAGES
Adult female elephant seals arrive on rookeries in the early winter
to give birth and nurse their young. This period is also coupled
with breeding and adult males overlap with adult females on land
only during this period. Females give birth to pups within several
days of arriving on land and nurse them for ∼25 days. Lactat-
ing females produce copious amounts of milk; nursing pups may
consume in excess of 4 kg of milk per day. The milk produced
by elephant seals is one of the most energy rich milks observed
in nature. It exceeds 50% lipid content by mass by the middle
of lactation and becomes more lipid rich with the progression of
lactation (11–13). Protein content remains stable across lactation
at ∼10% of the milk composition by mass. The milk contains
negligible carbohydrate. Endogenous lipid reserves are mobilized
at a high rate to support lactogenesis and maternal maintenance
metabolism (14). Adult females may lose up to 57% of their fat
mass and 25% of their body protein over the lactation period (13).
Elephant seal pups are abruptly weaned when their mothers
return to sea to feed. During the three-and-a-half week lacta-
tion period, pups will increase from a birth mass of ∼35 kg to
in excess of 120 kg. Body composition at weaning is typically 40–
50% lipid, almost all of which is contained within the blubber
layer (15). Upon weaning, pups undertake a post-weaning fast
that can extend beyond 8 weeks in duration. Pups spend increas-
ing amounts of time in surf zone waters with the progression of the
fast in order to learn the skills necessary for swimming and diving
at sea. At the same time, endogenous nutrients are mobilized for
the de novo synthesis of blood and respiratory pigments necessary
for extended breath-holds while diving (16).
Adult male elephant seals arrive on land in late autumn to
early winter for the breeding season. Combative intrasexual com-
petition between adult males is used to establish a dominance
hierarchy that ultimately contributes to breeding access to females.
Males may fast from food and water for up to 4 months during the
breeding season and may expend a considerable amount of energy
in breeding activities. Males may lose nearly a quarter of their body
mass prior to returning to sea to feed (17, 18).
Elephant seals return to land either in the spring (females)
or summer (males) to molt, following the post-breeding period
return to sea to feed. During this “catastrophic” molt the entire
pelage is shed and replaced. Although it has not been directly quan-
tified, the production of a new pelage must affect protein mobi-
lization and use and likely places different constraints on glucose
metabolism than does lactation or post-weaning development.
GLUCOSE PRODUCTION
The final report of the National Cholesterol Education Program
(NCEP) presented clinical criteria for defining the metabolic
syndrome (19). The NCEP proposed that three of five criteria
be met for the clinical diagnosis of the metabolic syndrome.
These included thresholds for abdominal obesity, triglyceride lev-
els, cholesterol levels (particularly low high-density lipoprotein,
HDL), hypertension, and impaired fasting glucose (≥100 mg/dL,
or 6.1 mM). A survey of how impaired fasting glucose alone com-
pared to individuals with metabolic syndrome showed that nearly
half of all individuals with impaired fasting glucose also met the
criteria for the metabolic syndrome (20). Although there is insuf-
ficient information to determine how all of these factors compare
to the natural state of the elephant seal, fasting glucose in the
elephant seal commonly exceeds the human threshold set by the
NCEP. Circulating glucose in fasting elephant seals ranges from
5.5 to 9.8 mM and varies with time fasting and the age class or
reproductive state of the seal (Table 1). The highest glucose levels,
which typically exceed 8 mM, are observed in elephant seals at the
beginning of their post-weaning fast. In this age class, there is a
modest decrease in plasma glucose with the progression of the fast.
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Within lactating females, glucose levels remain relatively constant
across the duration of the fast, although the total length of the fast
is substantially shorter than that of the weanling seals.
Endogenous glucose production (EGP) has been measured in
all classes of elephant seal. Rates of EGP in weanlings range from
1.0 to 1.8 mmol/min between the early and late fasting periods and
show of trend of declining EGP with time fasting (15, 21, 22). Total
EGP averages between 3.3 and 3.9 mmol/min and trends down-
ward with the progression of lactation in females, although this
trend disappears once corrected for body mass (23). Adult females
that have recently molted have rates of EGP that are intermediate
of early and late lactation values (23). A decline in EGP with time
fasting is consistent with the fasting-associated down-regulation
of glucose metabolism; however, the rate of glucose production
in elephant seals fasting for 1–3 months is comparable to that of
post-absorptive animals when controlling for mass (24). Figure 1
demonstrates the relationship between mass and EGP across a
broad range of animal masses under post-absorptive and fasting
conditions.
Maintaining relatively high levels of EGP across the fast is
likely controlled in part by fasting-dependent changes in regu-
latory hormones and adipocytokines, factors which are consistent
with observations of the metabolic syndrome. These factors not
only affect specific signaling pathways, but the mobilization of
nutrients for glucose synthesis. Recent investigations have shown
that EGP in fasting weanlings is not derived from glycogen stores
(15, 21). This finding is consistent with an expectation of glyco-
gen depletion over extended fasts. Protein is strictly conserved
across the post-weaning fast and the loss of amino acids to glu-
coneogenesis is minimized (15, 25–27). However, the ability to
conserve protein stores is progressively lost across lactation in adult
females due to the combined demands of lactation and mainte-
nance metabolism (28). The contribution of glycerol to EGP is
sufficient to replace the glucose that is lost to oxidation (see below),
but in both adult females and weanlings, glycerol gluconeogenesis
contributes <5–10% to EGP (14, 21).
Evidence gathered to date, including the nuclear magnetic reso-
nance (NMR) measurement of pathway flux rates associated with
the tricarboxylic acid (TCA) cycle, point to phosphoenolpyruvate
(PEP) as the dominant gluconeogenic precursor within fasting
elephant seals (21). Indeed, within weanling seals, PEP accounts
for ∼95% of EGP and the contribution of PEP to gluconeogen-
esis declines in direct relation to fasting-related reductions in the
rate of EGP. The origin of PEP for gluconeogenesis is likely the
lactate-pyruvate pool (29), and it has been hypothesized that high
rates of phosphoenol pyruvate carboxykinase (PEPCK) and pyru-
vate cycle activity exist to facilitate EGP by replacing TCA cycle
intermediates without loss of protein (amino acids) to anaplerotic
reactions (21).
It has long been known that the metabolic rate of the fasting
elephant seal is predominantly met by the oxidation of fat while
protein contributes little to meeting the metabolic demand (25–27,
FIGURE 1 | A comparison of endogenous glucose production
between fasting seals and other terrestrial mammals. Terrestrial
mammals are separated as those that are post-absorptive (open
squares) and those that have been fasting for 24 or more hours
(filled squares). Elephant seals are separated according to whether
measurements were made during the early or late fasting period
(see text for details on fasting duration as a function of life history
stage).
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30). Minimal contributions of glucose oxidation to the metabolic
rate have historically been determined by subtraction of energy
derived from protein and lipid oxidation from the whole animal
metabolic rate. However, recent measurements of the respiratory
quotient in weanling seals has shown that glucose oxidation con-
tributes <10% to the metabolic rate across the fast (15). Between
16 and 24% of EGP is oxidized and the amount oxidized is tightly
coupled to the rate of EGP, which declines with time fasting.
Available pathways for the non-oxidative disposal of glucose
consist of glycogen production, lipogenesis, and the production of
lactate, pyruvate, and alanine. Although nearly all glucose enters
glycolysis, there is no evidence for lipogenesis or the creation
of glycogen via the direct pathway through glucose 1-phosphate
(15). This suggests that glucose is converted to one of the poten-
tial gluconeogenic precursors and subsequently recycled via a
3-carbon intermediate (e.g., lactate), consistent with the findings
of Champagne et al. (24) and Tavoni et al. (29).
REGULATION OF GLUCOSE METABOLISM
INSULIN AND INSULIN RESISTANCE
By most accounts the definition of the metabolic syndrome cen-
ters around insulin resistance, a factor which will be demonstrated
also exists in the fasting elephant seal. However, a critical distinc-
tion between the human pathological condition and the adaptive
condition of the elephant seal is the occurrence of hyperinsuline-
mia. In man, the metabolic syndrome and the progression to type
2 diabetes is defined in part by the presence of hyperinsulinemia –
first in post-prandial measures, and later during fasting (31). This
hyperinsulinemia is, however, never observed in elephant seals.
Insulin levels are consistently low across all classes of elephant seal
(Table 1). Maximum levels of circulating insulin are <20 pM and
fall to ≤13.2 pM during the late portion of the lactating fast and
≤9.8 pM late in the post-weaning fast. This feature is likely adap-
tive to the extent that it facilitates lipolysis and allows the elephant
seal to maximize use of its copious adipose stores for meet-
ing metabolic demands. Numerous mechanisms of how insulin
inhibits lipolysis, and how the lack of insulin secretion facilitates
lipolysis, have been investigated (32). The reduction in insulin
responsiveness to glucose, as well as an increase in insulin resis-
tance, may very well be a conserved feature of the fasting response
(4, 5, 9), albeit taken to the extreme in the northern elephant seal.
Reductions in circulating insulin parallel the sensitivity of pan-
creatic β-cells, at least as measured in lactating females. Early dur-
ing lactation, a 150-g intravenous injection of glucose resulted in a
∼129% increase in circulating insulin 10 min post-injection (37).
No insulin response to the same glucose tolerance test (GTT) was
observed during late lactation, whereas post-molt females demon-
strated an intermediate response, increasing insulin by ∼62%.
Similar types of GTTs have been attempted in pups just prior
to weaning and those fasted for 8–11 weeks. The authors reported
no insulin response to a 25-g glucose challenge in either nutri-
tional state, i.e., fasting vs. feeding (34, 38). Collectively, these
findings suggest pancreatic β-cells have a reduced responsiveness
to circulating glucose, either inherently (e.g., genetic) or through
variability in epigenetic expression of metabolic control points.
A relationship between the proportion of body mass due to
adipose and the degree of insulin response following a GTT has
been offered as evidence that depletion of adipose stores relates to
functional suppression of the insulin response (37). This expla-
nation is not consistent with the findings of Kirby and Ortiz
(38) as pups tested in this study were in both feeding (adipose
gaining) and fasting (adipose depleting) states. A more parsimo-
nious explanation may be that a prolonged state of hyperlipidemia,
specifically high levels of certain circulating non-esterified fatty
acids (NEFAs), contributes to a decline in the ability of pancreatic
β-cells to respond to an increase in the glucose load as has been
observed both in vivo and in vitro (39, 40). In female elephant
seals, the increase in NEFA from 1.0 to 3.2 mM across the 25-day
lactation fast constitutes a progressive and continuous exposure to
elevated levels of NEFA that may explain the muted response in
glucose stimulated insulin secretion (GSIS). The lack of an insulin
response in weanlings measured prior to weaning and after 8–
11 weeks of fasting can be explained by a similar mechanism. While
nursing, pups are consuming large quantities of lipid and may
consume in excess of 4 L of milk per day by the end of lactation,
>50% of which is lipid (12, 13, 41). Thus, there is no shortage of
NEFA availability while nursing. Conversely, pups continue to be
exposed to NEFA levels between 0.7 and 1.6 mM throughout the
post-weaning fast. From birth to the end of the fast, pups therefore
experience a persistent exposure to high levels of NEFA.
Several lines of evidence also suggest peripheral insulin resis-
tance in both adult female seals and pups. Following a GTT,
adult females showed no relationship between a calculated glu-
cose tolerance index and the amount of insulin secreted per
minute, although the time fasting and life history stage (lactat-
ing vs. molting) had a significant influence over GSIS (37). The
insulin sensitivity index, calculated as the ratio of the area under
the curve for glucose to that for insulin, also suggested periph-
eral insulin resistance with a slight increase in resistance with time
fasting in the lactating females. Insulin tolerance tests (ITTs) con-
ducted in fasting weanlings and nursing pups are also indicative
of peripheral insulin resistance and an increase in peripheral resis-
tance with time fasting (34, 38). Interestingly, with the onset of the
post-weaning fast and the cessation of consuming high-fat content
milk, it appears that GSIS in the pups may temporarily return to a
state more similar to that of non-insulin resistant mammals (34).
Reductions in the phosphorylated forms of insulin receptor
(IR), insulin receptor substrate-1 (IRS-1), and expression of the
Akt2 gene within adipose tissue and with time fasting are also sug-
gestive of mounting insulin resistance in elephant seal weanlings
(35). This apparent reduction in insulin signaling is accompa-
nied by an increase in the expression of the plasma membrane
glucose transporter 4 (Glut-4) within the same adipose tissue
(35). Since Glut-4 is responsible for the cellular uptake of glu-
cose, the increased glucose uptake by the diminishing adipose
depot may partially explain the modest reductions in EGP and
circulating glucose concentrations observed between the early and
late periods of the post-weaning fast. An increase in the phospho-
rylation of AMPK within adipose tissue, which is observed late
in the fast (34), has been hypothesized as an insulin-independent
mechanism by which Glut-4 translocation might facilitate modest
reductions in circulating glucose levels. Indeed, after 6–8 weeks of
fasting, the expression of AMPK increases by 50% in response to
a GTT given to elephant seal pups, yet no change was observed
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in those fasting for only 2–3 weeks (34). Increased glucose uptake
by a variety of tissues may be an important feature contribut-
ing to reduced circulating glucose concentration and decreased
risk of metabolic syndrome. Increased glucose uptake leading to
reduced circulating glucose concentrations and subsequent allevi-
ation of the diabetic-like state has even recently been hypothesized
to explain why gastric bypass surgery reverses diabetes in subjects
before subsequent weight loss occurs (42).
CORTISOL
Elevations in cortisol have been implicated as a contributing factor
to the development of the metabolic syndrome. Glucocorticoids,
in particular cortisol, are known to enhance EGP and contribute to
hepatic and extrahepatic insulin resistance (43), thus promoting
hyperglycemia. Under acute elevations, cortisol is also known to
facilitate lipolysis and affect the regulation of NEFA metabolism
(44); however, under chronically elevated conditions, its role in
regulating NEFA remains uncertain, although it may have differ-
ent modes of action depending upon the specific adipose depot
targeted (45).
Cortisol increases with time fasting in lactating females and
weanlings (Table 1) and has been correlated with changes
in peripheral insulin resistance within weanlings (34). Similar
fasting-dependent variations in cortisol concentrations are not
observed in adult males, although levels across the fast are sim-
ilar to the highest levels observed in adult females and weanlings.
Furthermore, cortisol is negatively correlated with body mass late
in the breeding fast suggesting a potential relationship between
endogenous nutrient reserves (i.e., adiposity) and cortisol pro-
duction in competitively breeding males (33). In all cases, fasting
levels exceed what might be considered “stressed” in humans. Pat-
terns of circulating cortisol correlate well with the development of
insulin resistance in elephant seals but elevations in cortisol are not
correlated with an increase in EGP or circulating glucose levels.
NON-ESTERIFIED FATTY ACIDS
The role of NEFA in the development of insulin resistance has
received much attention. Fasts as short as 24-h, which substan-
tially increase circulating NEFA levels, have been shown to reduce
both the acute glucose-stimulated insulin response and insulin
sensitivity in human subjects (46). Both hepatic and peripheral
insulin resistance are facilitated by elevations in NEFA and a recent
review of the important role of adipose tissue in regulating meta-
bolic pathways during fasting has recently been made (47). As in
all mammals studied, NEFA increases with time fasting in the ele-
phant seal (Table 1) and, like cortisol, NEFA has been related to
changes in peripheral insulin resistance within this species (34).
Measurements of lipolysis in lactating females suggests that the
increase in NEFA with time fasting is not related to changes in
lipolysis (14), leaving reduced uptake and decreased reesterifi-
cation as mechanisms underlying the observed hyperlipidemia.
In weanlings, no direct measure of lipolysis has been made, but
an increase in adipose triglyceride lipase (ATGL) is suggestive of
increased lipolysis with time fasting. However, reduced periph-
eral uptake of NEFA due to the depressed expression of fatty
acid translocase (CD36), fatty acid transport protein (FATP1), or
modulation of reesterification via PEPCK are also associated with
increasing NEFA levels (36).
The role of obesity and fatty acids in the development of insulin
resistance has been recommended for re-evaluation based on accu-
mulating evidence that elevated NEFA is not necessarily related to
insulin resistance and that insulin resistance can exist in obesity
without elevations in NEFA (48). The distinctions of this debate
will not be discussed here, but it is important to note several char-
acteristics of elephant seal lipid stores and mobilization that might
have relevance to the issue. First, lipid stores in the elephant seal
are contained almost exclusively in the blubber and there is neg-
ligible visceral fat. The fat depot can approach 50% of the seal’s
mass. Though obese by human standards, this level of adiposity is
completely normal for this species; in fact, fatter seals are generally
considered to have a better overall body condition. Second, the
total lipid profile is markedly different within fasting adult males,
which may or may not be reflected in the other age categories
but which is certainly closer within the seals than in comparison
to humans. Specifically, levels of total cholesterol and low density
lipoprotein are elevated relative to humans but do decline with
time fasting, from 10.2 to 6.9 mM and 4.2 to 2.0 mM, respectively
(49). High-density lipoprotein is also high but is maintained across
the breeding fast in males ranging from 4.6 to 5.7 mmol/L, well in
excess of the threshold below which NCEP sets as one of the defin-
ing criteria of the metabolic syndrome (HDL≤1.03 mM for males,
≤1.29 mM for females). Third, the fat depot is derived exclusively
from the consumption of marine organisms and although the
characterization of blubber stores has not been completed in adult
elephant seals, the blubber layer of weanlings is dominated by
the presence of short-chained mono-unsaturated fatty acids (SC-
MUFAs) (50). The fatty acid composition of the blubber of the
closely related southern elephant seal (Mirounga leonina) con-
sists mostly of polyunsaturated fatty acids (PUFA) and both long
and short-chained MUFA (51) and it is expected that the north-
ern elephant seal would have similar overall distributions. Thus,
it is likely that the profile of mobilized NEFA during fasting is
substantially different than that of many humans experiencing
or developing the metabolic syndrome, although the variability
may be geographically dependent (i.e., diets of westernized cul-
tures vs. Pacific island populations). This is important as certain
NEFA constituents, particularly MUFA, have putative protective
properties from cardiovascular disease and the prevention of the
metabolic syndrome (52, 53). How the mobilization of NEFA and
the overall lipid profile therefore relate to the adaptive nature of
insulin resistance in the elephant seal remains unknown, but might
provide useful insight into the pathology of insulin resistance in
humans.
GLUCAGON
It has been suggested that elephant seals do not regulate glucose via
the typical insulin and glucagon push-pull model (38). However,
significant relationships between proportional glucose cycle activ-
ity and the ratio of plasma insulin to glucagon (I:G) have been
observed (23), and there is a consistent reduction in I:G between
early and late fasting periods across all studies to date (Table 1).
Specific action of either hormone is difficult to determine as any
causative relationship to glucose kinetics is clouded by the fact
that, although changes in I:G with time fasting are consistent, the
changes in glucagon levels with time fasting are variable across
studies and life history state of the seal.
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ADIPOCYTOKINES
Several adipocytokines have been implicated in the development
of insulin resistance in human populations. Leptin levels have been
correlated with the metabolic syndrome and may vary as a func-
tion of ethnicity and gender (54–56). Conversely, low levels of
adiponectin have been correlated with multiple physiological fea-
tures of the metabolic syndrome as well as type 2 diabetes (57,
58). A recent investigation of adult men suggests that the ratio of
adiponectin to leptin may be an important indicator of several
factors related to the metabolic syndrome (59). Only a couple of
studies have investigated variations in adipocytokines in elephant
seals, but the results of these studies are enlightening.
Leptin levels in elephant seal weanlings do not change with time
fasting or vary with changes in adiposity (34). In adult males, there
is a small decrease in leptin with time fasting but no relationship
to fat mass (33). Thus, there does not seem to be a relationship
between variations in leptin and insulin resistance. Adiponectin
significantly decreases and tumor necrosis factor-α (TNF-α) sig-
nificantly increases across the fast in weanlings (34, 35, 60). The
patterns of decreasing adiponectin, decreasing adiponectin/leptin
ratio, and increasing TNF-α are consistent with increasing insulin
resistance observed in this species. However, the relationship of
either leptin or adiponectin to other cardiovascular risk factors
typical of humans (e.g., total cholesterol) has not yet been deter-
mined in elephant seals, so it remains to be seen whether such
relationships exist and how the expression of these compounds
relate to the fasting capabilities of the elephant seal. The study of
adipocytokines is relatively new in the elephant seal model, but
future efforts will need to explore relationships of other adipocy-
tokines to the physiological traits that characterize elephant seal
fasting, particularly those adipocytokines that are thought to be
offensive in humans when over-expressed by adipose tissue (e.g.,
PAI-1or visfatin).
THE ADAPTIVE VALUE OF HIGH EGP AND INSULIN
RESISTANCE
Although fasting elephant seals demonstrate some characteristics
that parallel those of the metabolic syndrome, particularly insulin
resistance and a fasting hyperglycemia, it is necessary to return
to the point that these characteristics are adaptive in this fasting-
adapted species. Beyond the contribution of insulin resistance to
diminishing glucose uptake and oxidation, which conserves valu-
able protein stores while fasting and promotes the use of copious
lipid stores for meeting metabolic demands, other aspects of ele-
phant seal physiology must be taken into consideration as they
have bearing on the interpretation of their modifications to glucose
metabolism. Of particular interest is the potential for elevations
in EGP to reflect the influence of periodic hypoxic events associ-
ated with apneustic breathing on land and breath-hold diving, as
well as the prevention of ketoacidosis while fasting. These factors
have been previously discussed (24) but are presented again here
for the sake of providing a more complete picture of the adaptive
potential of fasting glucose metabolism in the elephant seal.
Some aspects of elephant seal fasting metabolism may reflect
adaptations to mitigating hypoxia and which potentially explain
deviations from characteristics of the metabolic syndrome.
Hypoxia is known to affect lipid and carbohydrate metabolic
pathways and elephant seals are repeatedly exposed to hypoxic
conditions and tissue ischemia because of their continuous breath-
hold diving while at sea and their apneustic breathing patterns
while on land (61–64). For example, hypoxia inducible tran-
scription factor (HIF) is responsible for mediating the effects of
hypoxic-ischemic stress. In low oxygen conditions it ceases to be a
target for enzymatic hydroxylation by intracellular oxygen sensors,
called prolyl hydroxylases (PHD), enabling it to transactivate the
genes responsible for adapting cellular pathways to hypoxic con-
ditions. Furthermore, selective disruption of certain hydroxylases,
specifically PHD-1, have been shown to further up-regulate HIF
expression. These conditions subsequently increase the use of
anaerobic pathways and affect various aspects of carbohydrate
metabolism, such as reducing pyruvate conversion to acetyl CoA,
suppressing its entrance into the TCA cycle, and increasing levels of
glycolytic enzymes and lactate dehydrogenase (65, 66). Although
many aspects of elephant seal glucose metabolism are consistent
with the upregulation of HIF, it remains to be determined as to
how or if adaptations to repeated hypoxic conditions have coe-
volved with the need to conserve endogenous nutrients during
fasting such that the typical mammalian response to prolonged
food deprivation has been modified (67, 68).
Another possible explanation for the fasting hyperglycemia
and high rates of EGP is that they are consequences of an up-
regulated TCA cycle for purposes of preventing ketoacidosis (15).
Although indices of incomplete NEFA β-oxidation (C6–C14 car-
nitines) increased with time fasting in weanlings (36), there is only
a modest accumulation of ketones (i.e., no ketoacidosis), and this
despite elephant seals meeting ∼90% or greater of their meta-
bolic demand through fat catabolism (13, 15, 17). During long
duration fasts undertaken by non-fasting-adapted species signif-
icant ketogenesis can occur, and in diabetes mellitus ketoacidosis
can occur as a pathological response to continued elevated rates
of lipid mobilization. The speculated cause of this phenomenon
is that the rate of fatty acid β-oxidation provides acetyl CoA at
rates that exceed the processing capacity of the TCA cycle. That an
up-regulated TCA cycle accommodates a high rate of fatty acid β-
oxidation in elephant seals is supported by NMR spectroscopy that
shows pyruvate cycling and the flux of carbon through PEPCK are
elevated relative to other mammalian species (21). Thus, whereas
hepatic and peripheral insulin resistance facilitates lipolysis and
glucose production, the latter may be further enhanced via mod-
ifications to anaplerotic pathways supporting the mitigation of
ketosis.
EVOLUTIONARY CONVERGENCE AMONG MARINE
MAMMALS?
Figure 2 provides a summary of changes in metabolic pathways
that occur with the progression of fasting in elephant seals. The
diagram is somewhat hypothetical in that it combines findings
from different age classes of seal, but it also demonstrates adap-
tive variations that may be shared with other marine mammals.
A common factor among all cetacean and pinniped species is
that they have evolved a secondary aquatic existence over tens
of millions of years while capitalizing on a diet that is high in
lipid and protein content but essentially devoid of carbohydrate.
The result of this dietary pressure may very well have produced a
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FIGURE 2 |Variations in metabolic pathways with time fasting that
contribute to insulin resistance in the northern elephant seals. The model
draws upon findings from multiple age classes and likely demonstrates age
and gender-specific variations. Dashed lines indicate reductions in metabolite
or hormone production, bold lines indicate increased production, and normally
weighted lines indicate no change. Arrows next to a metabolite or hormone
indicate either increased levels (upward arrow) or decreased levels
(downward arrow). (EGP, endogenous glucose production; NEFA,
non-esterified fatty acids; TNF-α, tumor necrosis factor alpha; IRS-1,
phosphorylated form of insulin receptor substrate; IR, phosphorylated form of
insulin receptor; Akt2, expression of the Akt2 gene; Glut-4, expression of the
plasma membrane glucose transporter 4.)
convergence of metabolic adaptations that parallel those of patho-
logical states in terrestrial mammals, particularly in humans where
an overabundance of energy rich foods taxes a system originally
designed for dealing with food shortages. The metabolic charac-
teristics of prolonged fasting in the elephant seal described here are
not unique to this species. Evidence obtained from other marine
mammals, including odontocete cetaceans (e.g., toothed whales
such as dolphins) and both otariid and phocid seals (i.e., sea lions
and fur seals, and true seals, respectively), suggests that the same
traits are expressed to some degree within many species of these
divergent, phylogenetic lineages. For example, high fasting blood
glucose is observed in a number of pinnipeds with widely vary-
ing fasting durations (69–72) and is even observed in dolphins
fasting for periods of several days (73). Other physiological par-
allels to the metabolic syndrome and diabetes mellitus have also
been noted (74); however, the degree to which there are paral-
lels varies according to the physiological ecology of the species.
For example, pups of both the subantarctic fur seal (Arctocephalus
tropicalis) and the northern elephant seal undergo extreme fasts
of up to 3 months, but the hormonal regulation of substrate uti-
lization during the fasts is markedly different, likely because of the
more restricted nutrient reserves in the smaller subantarctic fur
seal (75).
SUMMARY
The physiological response to fasting shared by mammals pro-
duces a state of insulin resistance that helps to conserve
endogenous protein stores from net loss via gluconeogenesis and
glucose oxidation and facilitates lipolysis in order to increase
the reliance upon fat oxidation to meet the organism’s meta-
bolic demands. In animals adapted to long-term fasting and
which predictably incorporate fasts as part of their life history,
the physiological modifications to fasting can be taken to the
extreme. Conversely, in the modern human era, chronic energy
surplus combined with reduced physical activity has resulted
in a set of conditions that contribute to insulin resistance and
increased morbidity, mainly excess fat deposition, lipid overflow
into non-adipose tissues, and subsequent inflammatory responses.
In the former condition the role of insulin resistance is adap-
tive, whereas in the latter it is pathological. Investigations of
insulin resistance in fasting-adapted marine mammals, such as
the northern elephant seal, might provide insight into the patho-
physiology of insulin resistance in humans and how it might
be better treated through pharmacological approaches. Given
that the marine mammals have evolved over millions of years
to live off of high energy diets rich in fat and protein and
nearly devoid of carbohydrate, it seems that a number of lessons
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regarding the issue of the metabolic syndrome in humans might
be learned.
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